NCT02215278

Brief Summary

Recent iron absorption studies with biofortified beans indicated that the currently developed beans do not provide an extra amount of iron compared to normal iron beans. This effect was ascribed to the inhibitory nature of phytic acid (PA), which is present in high concentrations. A possible solution to alleviate problems associated with the high PA concentration in beans might be low phytic acid (lpa) bean seeds. These beans, which exhibit a good agronomic performance, were tested in a human absorption study in Switzerland and provided a higher amount of bioavailable iron compared to their parent beans with normal PA concentrations. However, the informative value of the study for the real life situation is limited due to the simple study design with a relatively large amount of isotopic label added extrinsically (≈30% of total iron). Furthermore, the study was conducted in iron sufficient women in a non-bean consuming population. Additional investigations are necessary to verify that iron bioavailability from lpa beans is high and that their performance is better compared to common biofortified beans in a real life situation. A multiple meal randomized crossover study in Rwandese women with low iron status will be done to measure iron absorption from three different beans (lpa bean line, biofortified high iron bean, normal iron bean as a control). During the study, the subjects will receive multiple meals to reduce the amount of extrinsic label, therefore more closely simulating hypothetical dietary iron intake from lpa beans. This will also allow to avoid an overestimation of the effect of inhibitors and to minimize the influence of intra subject day to day variation. The study will be divided into two parts. In part one, two of the three bean varieties will be fed as part of composite meals over several days (morning and lunch) and in part two, the remaining bean will be administered as part of composite meals over several days (morning and lunch). Iron absorption from the three varieties will be measured and compared with erythrocyte incorporation of stable isotopic labels 14 days after test meal administration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 12, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 13, 2014

Completed
Last Updated

August 16, 2018

Status Verified

August 1, 2018

Enrollment Period

2 months

First QC Date

June 12, 2014

Last Update Submit

August 15, 2018

Conditions

Keywords

iron biofortificationlpa beanstable iron isotope studyphytic acid

Outcome Measures

Primary Outcomes (1)

  • Iron bioavailability from lpa bean variety compared to an iron biofortified variety

    Iron bioavailability is determined by measuring the amounts of isotopic labels in blood 14 d after administration of the test meals. It is calculated on the basis of the shift in iron isotope ratios and on the estimated amount of iron circulating in the body. Circulating iron is calculated based on the blood volume estimated from height and weight and measured Hb concentration. The calculations are based on the principles of isotope dilution. For calculation of fractional absorption, 80% incorporation of the absorbed Fe into red blood cells is assumed. Isotopic analysis are performed by negative thermal ionization mass spectrometry using a magnetic sector field mass spectrometer equipped with a multi-collector system for simultaneous ion beam detection

    2 month

Study Arms (3)

low phytic acid bean (lpa variety)

EXPERIMENTAL
Dietary Supplement: 10 x 55 g/ bean per arm

high iron biofortified bean variety

EXPERIMENTAL
Dietary Supplement: 10 x 55 g/ bean per arm

normal iron, normal phytic acid bean

EXPERIMENTAL
Dietary Supplement: 10 x 55 g/ bean per arm

Interventions

10 x 55 g/ bean per armDIETARY_SUPPLEMENT
high iron biofortified bean varietylow phytic acid bean (lpa variety)normal iron, normal phytic acid bean

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • non pregnant women, non lactating women
  • years
  • \<65 kg

You may not qualify if:

  • metabolic, chronic or gastrointestinal disease
  • long term medication
  • blood donation within the last 6 month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rwanda

Butare, Huye, Rwanda

Location

Related Publications (1)

  • Petry N, Rohner F, Gahutu JB, Campion B, Boy E, Tugirimana PL, Zimmerman MB, Zwahlen C, Wirth JP, Moretti D. In Rwandese Women with Low Iron Status, Iron Absorption from Low-Phytic Acid Beans and Biofortified Beans Is Comparable, but Low-Phytic Acid Beans Cause Adverse Gastrointestinal Symptoms. J Nutr. 2016 May;146(5):970-5. doi: 10.3945/jn.115.223693. Epub 2016 Mar 30.

Study Officials

  • Nicolai Petry, PhD

    GroundWork

    PRINCIPAL INVESTIGATOR
  • Diego Moretti, PhD

    ETH Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. of Science ETH

Study Record Dates

First Submitted

June 12, 2014

First Posted

August 13, 2014

Study Start

February 1, 2014

Primary Completion

April 1, 2014

Study Completion

May 1, 2014

Last Updated

August 16, 2018

Record last verified: 2018-08

Locations